Abstract
All 58 subjects working at a department of cardiac surgery and intensive care unit were screened for HBsAg, anti-HBc and anti-HBs. Overall positivity for HBV markers was 24% and was found to increase with length of employment in the department. Of the 44 seronegative subjects, 33 consented to receive 5 μg hepatitis B vaccine (Hevac B Pasteur) at 0-time and 1 and 2 months later. At screening of 31 subjects one month after the third dose of the vaccine, 30 showed anti-HBs with a mean titre of 110 MIU/ml (range 60-127). Mild and self-limiting side effects were observed.
| Original language | English |
|---|---|
| Pages (from-to) | 936-941 |
| Number of pages | 6 |
| Journal | Igiene Moderna |
| Volume | 83 |
| Issue number | 6 |
| Publication status | Published - 1985 |
Fingerprint
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health
Cite this
Active immunization against hepatitis B for the staff of a department of cardiac surgery. / Scalise, G.; Urbani, C.; Clementi, M.
In: Igiene Moderna, Vol. 83, No. 6, 1985, p. 936-941.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Active immunization against hepatitis B for the staff of a department of cardiac surgery
AU - Scalise, G.
AU - Urbani, C.
AU - Clementi, M.
PY - 1985
Y1 - 1985
N2 - All 58 subjects working at a department of cardiac surgery and intensive care unit were screened for HBsAg, anti-HBc and anti-HBs. Overall positivity for HBV markers was 24% and was found to increase with length of employment in the department. Of the 44 seronegative subjects, 33 consented to receive 5 μg hepatitis B vaccine (Hevac B Pasteur) at 0-time and 1 and 2 months later. At screening of 31 subjects one month after the third dose of the vaccine, 30 showed anti-HBs with a mean titre of 110 MIU/ml (range 60-127). Mild and self-limiting side effects were observed.
AB - All 58 subjects working at a department of cardiac surgery and intensive care unit were screened for HBsAg, anti-HBc and anti-HBs. Overall positivity for HBV markers was 24% and was found to increase with length of employment in the department. Of the 44 seronegative subjects, 33 consented to receive 5 μg hepatitis B vaccine (Hevac B Pasteur) at 0-time and 1 and 2 months later. At screening of 31 subjects one month after the third dose of the vaccine, 30 showed anti-HBs with a mean titre of 110 MIU/ml (range 60-127). Mild and self-limiting side effects were observed.
UR - http://www.scopus.com/inward/record.url?scp=0022253474&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022253474&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0022253474
VL - 83
SP - 936
EP - 941
JO - Igiene Moderna
JF - Igiene Moderna
SN - 0019-1655
IS - 6
ER -